Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunohistochemical analysis‐based proteomic subclassification of newly diagnosed glioblastomas

3 Jul 2012

Abstract excerpt

Recent gene expression and copy number profilings of glioblastoma multiforme (GBM) by The Cancer Genome Atlas (TCGA) Research Network suggest the existence of distinct subtypes of this tumor. However, these approaches might not be easily applicable in routine clinical practice. In the current study, we aimed to establish a proteomics-based subclassification of GBM by integrating their genomic and epigenomic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Epigenetics and DNA Methylation
Share to Glioma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22747609
DOI: 10.1111/j.1349-7006.2012.02377.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunohistochemical analysis‐based proteomic subclassification of newly diagnosed glioblastomasPMID 22747609Read ↗

Current Opinion on Molecular Characterization for GBM Classification in Guiding Clinical Diagnosis, Prognosis, and TherapySemantic proximity Read ↗

Applicable advances in the molecular pathology of glioblastoma.Semantic proximity Read ↗

Comprehensive understanding of glioblastoma molecular phenotypes: classification, characteristics, and transition.Semantic proximity Read ↗

Glioblastoma with oligodendroglioma component (GBM-O): molecular genetic and clinical characteristics.Semantic proximity Read ↗

Genomics and proteomics to determine novel molecular subtypes and predict the response to immunotherapy and the effect of bevacizumab in glioblastoma.Semantic proximity Read ↗

DNA Methylation-Based Deconvolution Study of Glioblastoma Heterogeneity and Cell Types Associated with Patient SurvivalSemantic proximity Read ↗

Transcriptome profiling-based identification of prognostic subtypes and multi-omics signatures of glioblastomaSemantic proximity Read ↗

Prevalence and Clinicopathologic Characteristics of the Molecular Subtypes in Malignant Glioma: A Multi-Institutional Analysis of 941 CasesSemantic proximity Read ↗

Glioblastoma with oligodendroglial component represents a subgroup of glioblastoma with high prevalence of IDH1 mutation and association with younger age.Semantic proximity Read ↗

Immunological profiles of human oligodendrogliomas define two distinct molecular subtypes.Semantic proximity Read ↗

Glioblastomas with Oligodendroglial Component – Common Origin of the Different Histological Parts and Genetic SubclassificationSemantic proximity Read ↗

Gene expression profiles of human glioblastomas are associated with both tumor cytogenetics and histopathologySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.